ATE172028T1 - Zytodiagnostisches verfahren unter verwendung von alstonin als selektivem marker und diesen marker enthaltender diagnostischer kit - Google Patents
Zytodiagnostisches verfahren unter verwendung von alstonin als selektivem marker und diesen marker enthaltender diagnostischer kitInfo
- Publication number
- ATE172028T1 ATE172028T1 AT93916038T AT93916038T ATE172028T1 AT E172028 T1 ATE172028 T1 AT E172028T1 AT 93916038 T AT93916038 T AT 93916038T AT 93916038 T AT93916038 T AT 93916038T AT E172028 T1 ATE172028 T1 AT E172028T1
- Authority
- AT
- Austria
- Prior art keywords
- marker
- pct
- alstonin
- cytodiagnostic
- selective
- Prior art date
Links
- WYTGDNHDOZPMIW-RCBQFDQVSA-N alstonine Chemical compound C1=CC2=C3C=CC=CC3=NC2=C2N1C[C@H]1[C@H](C)OC=C(C(=O)OC)[C@H]1C2 WYTGDNHDOZPMIW-RCBQFDQVSA-N 0.000 title abstract 4
- 239000003550 marker Substances 0.000 title abstract 3
- 238000009007 Diagnostic Kit Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- QVBOOBQEGOUUGN-RCBQFDQVSA-N alstonine Chemical compound C1=C[CH]C2=NC3=C(C[C@@H]4C(C(=O)OC)=CO[C@@H](C)[C@@H]4C4)[N+]4=CC=C3C2=C1 QVBOOBQEGOUUGN-RCBQFDQVSA-N 0.000 abstract 2
- 238000001514 detection method Methods 0.000 abstract 2
- 239000000032 diagnostic agent Substances 0.000 abstract 2
- 229940039227 diagnostic agent Drugs 0.000 abstract 2
- 208000031404 Chromosome Aberrations Diseases 0.000 abstract 1
- 231100000005 chromosome aberration Toxicity 0.000 abstract 1
- 230000002559 cytogenic effect Effects 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 238000005259 measurement Methods 0.000 abstract 1
- 230000002980 postoperative effect Effects 0.000 abstract 1
- 210000004881 tumor cell Anatomy 0.000 abstract 1
- 230000001173 tumoral effect Effects 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/52—Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/808—Optical sensing apparatus
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/81—Packaged device or kit
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/968—High energy substrates, e.g. fluorescent, chemiluminescent, radioactive
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/805—Optical property
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/811—Test for named disease, body condition or organ function
- Y10S436/813—Cancer
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/815—Test for named compound or class of compounds
- Y10S436/816—Alkaloids, amphetamines, and barbiturates
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Food Science & Technology (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Sampling And Sample Adjustment (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9209283A FR2694193B1 (fr) | 1992-07-28 | 1992-07-28 | Méthode de cytodiagnostic utilisant l'alstonine comme marqueur sélectif et kit de diagnostic contenant ce marqueur. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE172028T1 true ATE172028T1 (de) | 1998-10-15 |
Family
ID=9432327
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT93916038T ATE172028T1 (de) | 1992-07-28 | 1993-07-26 | Zytodiagnostisches verfahren unter verwendung von alstonin als selektivem marker und diesen marker enthaltender diagnostischer kit |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US5567593A (de) |
| EP (1) | EP0605701B1 (de) |
| JP (1) | JPH07503323A (de) |
| AT (1) | ATE172028T1 (de) |
| BR (1) | BR9305588A (de) |
| CA (1) | CA2120002C (de) |
| DE (1) | DE69321454T2 (de) |
| ES (1) | ES2126652T3 (de) |
| FR (1) | FR2694193B1 (de) |
| WO (1) | WO1994002829A1 (de) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6136540A (en) * | 1994-10-03 | 2000-10-24 | Ikonisys Inc. | Automated fluorescence in situ hybridization detection of genetic abnormalities |
| AU1808400A (en) * | 1998-10-29 | 2000-05-22 | Merck & Co., Inc. | Dihydropyridinones and pyrrolinones useful as alpha 1a adrenoceptor antagonists |
| EP1147400B1 (de) * | 1999-11-09 | 2009-03-04 | Raytheon Company | Abbildungssystem zum nachweis von fluoreszierenden organischen substanzen in einer probe |
| EP1405058A4 (de) | 2001-03-19 | 2007-07-04 | Ikonisys Inc | System und verfahren zur erhöhung des kontrasts eines durch ein epifluoreszenzmikroskop erzeugten bildes |
| KR20030046063A (ko) * | 2001-12-04 | 2003-06-12 | 이성문 | 음식물 찌꺼기와 식물성 찌꺼기를 이용하여 칼슘석회석과(Caco3) 마그네슘(MGO) 장석운모 바이오와재오라이트석 가루를 60매시로 배합하여 숙성시킨칼슘석회질 유기질 비료 제조방법. |
| WO2006053649A1 (en) * | 2004-11-19 | 2006-05-26 | Nowicky Wassili | Method for the detection of cancer |
| WO2006053680A1 (en) * | 2004-11-19 | 2006-05-26 | Nowicky Wassili | Ex vivo cancer diagnostic method |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4160018A (en) * | 1973-06-25 | 1979-07-03 | Bjorklund Knut B | Stabilized cancer associated polypeptide antigen and preparation thereof |
| FR2439783A1 (fr) * | 1978-03-13 | 1980-05-23 | Beljanski Mirko | Procede d'extraction de la serpentine et de l'alstonine |
| FR2419725A1 (fr) * | 1978-03-13 | 1979-10-12 | Beljanski Mirko | Serpentine, alstonine et sempervirine, medicaments inhibant specifiquement les cellules cancereuses et tumorales |
| EP0059817B1 (de) * | 1981-03-11 | 1985-10-09 | Mirko Beljanski | Serpentin, Alstonin und Sempervirin, Medikamente, die die Tumor- und Krebszellen spezifisch hemmen |
| US4649151A (en) * | 1982-09-27 | 1987-03-10 | Health Research, Inc. | Drugs comprising porphyrins |
| AT387860B (de) * | 1985-09-16 | 1989-03-28 | Optical Sensing Technology | Verfahren und vorrichtung zur tumordiagnose mittels sera |
| US5283255A (en) * | 1987-01-20 | 1994-02-01 | The University Of British Columbia | Wavelength-specific cytotoxic agents |
-
1992
- 1992-07-28 FR FR9209283A patent/FR2694193B1/fr not_active Expired - Fee Related
-
1993
- 1993-07-26 US US08/196,165 patent/US5567593A/en not_active Expired - Lifetime
- 1993-07-26 ES ES93916038T patent/ES2126652T3/es not_active Expired - Lifetime
- 1993-07-26 EP EP93916038A patent/EP0605701B1/de not_active Expired - Lifetime
- 1993-07-26 AT AT93916038T patent/ATE172028T1/de not_active IP Right Cessation
- 1993-07-26 WO PCT/FR1993/000762 patent/WO1994002829A1/fr not_active Ceased
- 1993-07-26 CA CA002120002A patent/CA2120002C/en not_active Expired - Fee Related
- 1993-07-26 DE DE69321454T patent/DE69321454T2/de not_active Expired - Fee Related
- 1993-07-26 JP JP6504225A patent/JPH07503323A/ja active Pending
- 1993-07-26 BR BR9305588A patent/BR9305588A/pt not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| FR2694193A1 (fr) | 1994-02-04 |
| DE69321454D1 (de) | 1998-11-12 |
| JPH07503323A (ja) | 1995-04-06 |
| FR2694193B1 (fr) | 1994-10-28 |
| CA2120002A1 (en) | 1994-02-03 |
| BR9305588A (pt) | 1995-05-30 |
| US5567593A (en) | 1996-10-22 |
| WO1994002829A1 (fr) | 1994-02-03 |
| EP0605701A1 (de) | 1994-07-13 |
| CA2120002C (en) | 2007-12-11 |
| ES2126652T3 (es) | 1999-04-01 |
| DE69321454T2 (de) | 1999-06-17 |
| EP0605701B1 (de) | 1998-10-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Novikova et al. | Persistent neuronal labeling by retrograde fluorescent tracers: a comparison between Fast Blue, Fluoro-Gold and various dextran conjugates | |
| FI955319A0 (fi) | 2-pyridyylimetyleenipolyatsamakrosyklofosfonihappoja, niiden komplekseja ja johdannaisia käytettäväksi vasta-aineina | |
| CY1111863T1 (el) | Αντισωματα εναντιον υποδοχεα θανατου 4 (dr4) και χρησεις αυτων | |
| DE69307495D1 (en) | Oligothionukleotide | |
| DE69104723D1 (de) | Hustenstillendes und schleimregulierendes mittel, verfahren zu seiner herstellung und dieses enthaltende pharmazeutische zusammensetzungen. | |
| ATE175201T1 (de) | Mono-n-substituierte 1,4,7,10- tetraazacyclododecan-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mittel | |
| BR9507140A (pt) | Proteina dna vetor célula capaz de expressar uma proteina kit e processo de teste preparado de luciferase e uso de uma luciferase | |
| ATE226953T1 (de) | 3-,8-substituierte deuteroporphyrinderivate, diese enthaltende pharmazeutische mittel und verfahren zu ihrer herstellung | |
| DE59404433D1 (de) | Meso-tetraphenylporphyrin-komplexverbindungen, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mittel | |
| ATE224736T1 (de) | Kombinationsprodukt, enthaltend eine nukleinsäure und eine substanz, die die extrazellulärematrix desorganisiert, zur verwendung in gentherapie | |
| DE60042066D1 (de) | Chimärische dr4 antikörper und ihre verwendung | |
| ATE172028T1 (de) | Zytodiagnostisches verfahren unter verwendung von alstonin als selektivem marker und diesen marker enthaltender diagnostischer kit | |
| ATE153342T1 (de) | Adenosinderivate, verfahren zu deren herstellung und pharmazeutische mittel | |
| DE2239936C2 (de) | Verfahren zur quantitativen Bestimmung von Peptidase-Enzymkonzentrationen in Homogenaten unter Verwendung von 4-Methoxy-2-naphthylamiden | |
| DE59510713D1 (de) | N-substituierte 3-azabicyclo(3.2.0)heptan-derivate als neuroleptika | |
| BR9408244A (pt) | Derivados de azabiciclo[3.2.0]heptano N-substituídos | |
| DE69302829D1 (de) | Bicyclische pyrimidinderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische präparate | |
| EP0353868A3 (de) | Fluoreszierende Phenalenimin-Farbstoffe und deren Verwendung für analytische Zusammensetzungen, Elemente und Verfahren | |
| EP0190299A1 (de) | NEUE p-PHENYLENDIAMIN-PEPTIDE UND DIESE ENTHALTENDE REAGENZIEN ZUR BESTIMMUNG VON PROTEASEN DES BLUTGERINNUNGSSYSTEMS | |
| DE59409767D1 (de) | Pharmazeutische zusammensetzung in form eines kits enthaltend prostaglandin e1 | |
| ATE212216T1 (de) | Oxidationsfärbemittel zum färben von keratinfasern, die eine spezielle kombination von entwicklerkomponenten und alkalisierungsmittel enthalten | |
| ATE195529T1 (de) | 17beta-(2-oxo-tetrahydrofuran-4-yl)-thio- androstane derivate (17beta-(gamma-buttersäure- lacton)-thio derivate) zur behandlung von entzündungen, pharmazeutische präparate davon und ein verfahren zu ihrer herstellung | |
| DE58908775D1 (de) | 2-Halogensubstituierte N-Indolylethyl-sulfonsäureamide, Verfahren zu ihrer Herstellung und ihre Verwendung in Arzneimitteln. | |
| DE59001431D1 (de) | 1-methoxypyrimidinyl-1h-1,2,4-triazol-3-sulfonsaeurenitroanilide, verfahren zu ihrer herstellung und ihre verwendung als mittel mit herbizider wirkung. | |
| Grote et al. | Studies on viburnum. III. The uterine sedative action of various fractions |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |